First human test of robotic eye surgery a success
Researchers from the University of Oxford have completed the first successful trial of robot-assisted retinal surgery.
Jun 18, 2018
0
1778
Researchers from the University of Oxford have completed the first successful trial of robot-assisted retinal surgery.
Jun 18, 2018
0
1778
(Medical Xpress)—A University of Arizona professor is overseeing the manufacture of an experimental drug that could help reduce brain damage after a stroke.
Sep 21, 2012
1
0
(Medical Xpress) -- Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have developed a novel biomimetic strategy that delivers life-saving nanotherapeutics directly to obstructed ...
Jul 5, 2012
0
0
(HealthDay) -- A medication called tenecteplase may be more effective at treating strokes caused by clots in large blood vessels in the brain than the current standard therapy, Australian researchers report.
Mar 22, 2012
0
0
A drug commonly used to treat patients suffering from strokes could be repurposed to treat patients with COVID-19, according to researchers at the University of Aberdeen.
May 4, 2020
0
4
Mobile devices proved both reliable and accurate for the clinical decision to administer IV thrombolysis in patients with acute stroke, according to an ahead-of-print article in the April issue of the American Journal of ...
Feb 12, 2020
0
1
A large study has found that commencing treatment for sleep apnea as soon as possible after a stroke or a mini-stroke significantly improves speech impairment and other neurological symptoms as well as walking and other physical ...
Sep 11, 2018
0
6
While the gold standard for stroke care is the use of IV tissue plasminogen activator (tPA, or product name Alteplase) to dissolve clots and mechanical thrombectomy to remove clots in severe to moderate strokes, researchers ...
Jul 10, 2018
0
0
A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, the most common type of stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug invented at The Scripps ...
Feb 20, 2018
0
41
(HealthDay)—Having a pharmacist at bedside during acute ischemic stroke is associated with significantly shorter door-to-needle (DTN) times, according to a study published recently in the Annals of Pharmacotherapy.
Jan 19, 2018
0
200